Patent ReferencesMethod of producing antibodies Patent #: 4196265 InventorsAssigneeApplicationNo. 06/033639 filed on 04/26/1979US Classes:530/388.75, Binds T-lymphocytic cell or component or product thereof (e.g., T cell, thymocyte, T-lineage bone marrow cell, T-lymphoblastoid cell, T-lineage acute lymphoblastic leukemia cell, T-lymphocytic cell-surface antigen, etc.)435/70.21, Producing monoclonal antibody435/966, INVOLVING AN ENZYME SYSTEM WITH HIGH TURNOVER RATE OR COMPLEMENT MAGNIFIED ASSAY (E.G., MULTI-ENZYME SYSTEMS, ETC.)436/548, Monoclonal antibody530/388.73, Binds lymphocytic or lymphocytic-like cell or component or product thereof (e.g., B cell, B-lineage bone marrow cell, null cell, natural killer cell, B-lymphoblastoid cell, B-lineage acute lymphoblastic leukemia cell, B-lymphocytic cell-surface antigen, etc.)530/808MATERIALS AND PRODUCTS RELATED TO GENETIC ENGINEERING OR HYBRID OR FUSED CELL TECHNOLOGY, E.G., HYBRIDOMA, MONOCLONAL PRODUCTS, ETC.ExaminersPrimary: Fagelson, Anna P.Attorney, Agent or FirmInternational ClassesC07K 16/30 (20060101)C07K 16/18 (20060101) C07K 16/28 (20060101) A61K 38/00 (20060101) AbstractHybrid cell line for production of monoclonal antibody to an antigen found on all normal human helper T cells. The hybrid is formed by fusing splenocytes from immunized CAF1 mice with P3X63Ag8U1 myeloma cells. Diagnostic and therapeutic uses of the monoclonal antibody are also disclosed.Other References
|
| ||||||||||||||